Kyung Dong Pharmaceutical Co. Ltd (011040) - Total Liabilities
Based on the latest financial reports, Kyung Dong Pharmaceutical Co. Ltd (011040) has total liabilities worth ₩79.70 Billion KRW (≈ $54.01 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Kyung Dong Pharmaceutical Co. Ltd - Total Liabilities Trend (2011–2025)
This chart illustrates how Kyung Dong Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Kyung Dong Pharmaceutical Co. Ltd to evaluate short-term liquidity relative to the company's equity base.
Kyung Dong Pharmaceutical Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Kyung Dong Pharmaceutical Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Compass Digital Acquisition Corp
NASDAQ:CDAQ
|
USA | $9.51 Million |
|
Webus International Limited Ordinary Shares
NASDAQ:WETO
|
USA | $27.44 Million |
|
Autocount Dotcom Berhad
KLSE:0276
|
Malaysia | RM13.04 Million |
|
J W Mays Inc
NASDAQ:MAYS
|
USA | $38.52 Million |
|
BaoMinh Insurance Corp
VN:BMI
|
Vietnam | ₫4.60 Trillion |
|
Neuronetics Inc
NASDAQ:STIM
|
USA | $108.38 Million |
|
Nexstim Oyj
HE:NXTMH
|
Finland | €9.17 Million |
|
Heng Sheng Holding Group Limited
KQ:900270
|
Korea | ₩52.60 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Kyung Dong Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Kyung Dong Pharmaceutical Co. Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kyung Dong Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
The table below shows the annual total liabilities of Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩93.02 Billion ≈ $63.04 Million |
+12.33% |
| 2024-12-31 | ₩82.81 Billion ≈ $56.12 Million |
+28.40% |
| 2023-12-31 | ₩64.49 Billion ≈ $43.71 Million |
+21.06% |
| 2022-12-31 | ₩53.27 Billion ≈ $36.10 Million |
+65.69% |
| 2021-12-31 | ₩32.15 Billion ≈ $21.79 Million |
+10.09% |
| 2020-12-31 | ₩29.21 Billion ≈ $19.79 Million |
-52.03% |
| 2019-12-31 | ₩60.88 Billion ≈ $41.26 Million |
+32.14% |
| 2018-12-31 | ₩46.08 Billion ≈ $31.23 Million |
+51.20% |
| 2017-12-31 | ₩30.47 Billion ≈ $20.65 Million |
+6.69% |
| 2016-12-31 | ₩28.56 Billion ≈ $19.36 Million |
+1.01% |
| 2015-12-31 | ₩28.28 Billion ≈ $19.16 Million |
-24.09% |
| 2014-12-31 | ₩37.25 Billion ≈ $25.24 Million |
+18.80% |
| 2013-12-31 | ₩31.35 Billion ≈ $21.25 Million |
-11.62% |
| 2012-12-31 | ₩35.48 Billion ≈ $24.04 Million |
+1.06% |
| 2011-12-31 | ₩35.10 Billion ≈ $23.79 Million |
-- |
About Kyung Dong Pharmaceutical Co. Ltd
Kyung Dong Pharmaceutical Co., Ltd. produces and sells specialized and general medicines in South Korea. It offers prescription medicines for liver therapy, antispasmodic, antidiabetic, antiviral, corticosteroid, androgen alopecia, muscle relaxant, antimigraine, vitamin, antifungal, endocrinal, urology, antibacterial, cardiovascular, pain/inflammation, smoking cessation aid, gastrointestinal, ant… Read more